LogicBio Therapeutics, a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect.
Revenue (Q2, 2020)
Net income (Q2, 2020)
EBIT (Q2, 2020)
Market capitalization (16-Oct-2020)
Closing stock price (16-Oct-2020)
|USD||Q2, 2017||Q2, 2018||Q3, 2018||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020|
Depreciation and Amortization
Cash From Operating Activities
LogicBio Therapeutics has 370 Twitter Followers. The number of followers has increased 2.4% month over month and increased 4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was LogicBio Therapeutics founded?
LogicBio Therapeutics was founded in 2014.
Who are LogicBio Therapeutics key executives?
LogicBio Therapeutics's key executives are Frederic Chereau, Fred Chereau and Matthias Jaffé.
How many employees does LogicBio Therapeutics have?
LogicBio Therapeutics has 41 employees.
Who are LogicBio Therapeutics competitors?
Competitors of LogicBio Therapeutics include Immunocore, Agenus and Rocket Pharmaceuticals.
Where is LogicBio Therapeutics headquarters?
LogicBio Therapeutics headquarters is located at 65 Hayden Ave, Lexington.
Where are LogicBio Therapeutics offices?
LogicBio Therapeutics has an office in Lexington.
How many offices does LogicBio Therapeutics have?
LogicBio Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies